Imaging
Lantheus acquires Meilleur, including global rights to PET imaging agent for Alzheimer’s
Lantheus Holdings Inc. has announced the acquisition of Meilleur Technologies Inc., which includes the transfer of its rights to an amyloid-beta positron emission tomography imaging agent.
Forefoot ‘can be omitted’ when using ultrasound to predict rheumatoid arthritis
Forefoot ultrasound adds little value when attempting to predict rheumatoid arthritis in patients with clinically suspect arthralgia, as positive findings there are “rare” without accompanying inflammation in the hands, according to data.
Synopsis and Assessment of the 2015 Gout Classification Criteria
Diagnosis of Gout and Use of Laboratory and Imaging
Imaging
Q&A: New pediatric guidance for advanced imaging in ED
New guidance from the AAP and other groups advises providers to weigh the benefits and risks of performing advanced imaging on children in the ED.
FDA clears mobile C-arm system for complex vascular imaging
Royal Philips announced the FDA 510(k) clearance and launch of image-guided therapy mobile C-arm system designed for complex vascular needs and clinical procedures such as cardiac interventions, pain management and urology.
Temporal artery ultrasound, EULAR criteria reliable diagnostics for giant cell arteritis
KIAWAH ISLAND, S.C. — Temporal artery ultrasound and EULAR score are reliable means for diagnosing giant cell arteritis, Mercy Bechtold, MD, said during her presentation at Kiawah Eye.
FDA grants 510(k) clearance to CT imaging analysis solution for intracerebral hemorrhage
The FDA has granted 510(k) clearance to a South Korea-based specialized medical AI startup for its non-contrast CT imaging analysis solution to detect intracerebral hemorrhage.
FDA grants fast track designation to PET tau imaging tracer
The FDA has granted fast track designation to a radioactive fluorinated positron emission tomography tracer for imaging tau protein in those with suspected progressive supranuclear palsy, according to the manufacturer.